NO20021937L - Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer - Google Patents

Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer

Info

Publication number: NO20021937L
Authority: NO; Norway
Prior art keywords: phosphodiesterase; administering; inhibitor
Prior art date: 1999-10-29

Application number

NO20021937A

Other languages

English (en)

Other versions

NO20021937D0 (no

Inventor

Robert D Murdoch

Theodore J Torphy

Barry D Zussman

Original Assignee

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-10-29

Filing date

2002-04-24

Publication date

2002-05-30

2002-04-24 Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc

2002-04-24 Publication of NO20021937D0 publication Critical patent/NO20021937D0/no

2002-05-30 Publication of NO20021937L publication Critical patent/NO20021937L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Inorganic Chemistry (AREA)
Neurosurgery (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Enzymes And Modification Thereof (AREA)

NO20021937A 1999-10-29 2002-04-24 Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer NO20021937L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US16247799P	1999-10-29	1999-10-29
US16264199P	1999-11-01	1999-11-01
US17981700P	2000-02-02	2000-02-02
PCT/US2000/029453 WO2001032165A1 (en)	1999-10-29	2000-10-26	Method for administering a phosphodiesterase 4 inhibitor

Publications (2)

Publication Number	Publication Date
NO20021937D0 NO20021937D0 (no)	2002-04-24
NO20021937L true NO20021937L (no)	2002-05-30

Family

ID=27388757

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20021937A NO20021937L (no)	1999-10-29	2002-04-24	Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer

Country Status (29)

Country	Link
US (1)	US20030212112A1 (no)
EP (1)	EP1225884A4 (no)
JP (1)	JP2003513038A (no)
KR (1)	KR20020050249A (no)
CN (1)	CN1387433A (no)
AP (1)	AP2002002446A0 (no)
AR (1)	AR026254A1 (no)
AU (1)	AU772909B2 (no)
BG (1)	BG106623A (no)
BR (1)	BR0015039A (no)
CA (1)	CA2389293A1 (no)
CO (1)	CO5271676A1 (no)
CZ (1)	CZ20021443A3 (no)
DZ (1)	DZ3249A1 (no)
EA (1)	EA200200502A1 (no)
HK (1)	HK1049105A1 (no)
HU (1)	HUP0203682A3 (no)
IL (1)	IL148813A0 (no)
MA (1)	MA25562A1 (no)
MX (1)	MXPA02004220A (no)
NO (1)	NO20021937L (no)
NZ (1)	NZ518002A (no)
OA (1)	OA12078A (no)
PE (1)	PE20011004A1 (no)
PL (1)	PL355262A1 (no)
SK (1)	SK7292002A3 (no)
TR (1)	TR200201150T2 (no)
UY (1)	UY26422A1 (no)
WO (1)	WO2001032165A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR029984A1 (es) *	2000-07-27	2003-07-23	Smithkline Beecham Corp	Metodo para reducir las exacerbaciones asociadas copd ambito
DE10207160A1 (de) *	2002-02-20	2003-12-18	Altana Pharma Ag	Darreichungsform enthaltend PDE 4-Hemmer als Wirkstoff
MY140561A (en)	2002-02-20	2009-12-31	Nycomed Gmbh	Dosage form containing pde 4 inhibitor as active ingredient
SI2020243T1 (sl) *	2002-05-28	2018-11-30	Astrazeneca Ab	Farmacevtski pripravek za topično uporabo
US6822114B1 (en)	2002-10-08	2004-11-23	Albemarle Corporation	Process for production of fluoroalkoxy-substituted benzamides and their intermediates
BRPI0406427B8 (pt)	2003-03-10	2021-05-25	Astrazeneca Ab	processo para a preparação de roflumilast
US20060239927A1 (en) *	2003-03-31	2006-10-26	Kyowa Hakko Kogyo Co.,	Drug for airway administration
US20050026883A1 (en) *	2003-07-31	2005-02-03	Robinson Cynthia B.	Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
WO2006097456A1 (en)	2005-03-16	2006-09-21	Nycomed Gmbh	Taste masked dosage form containing roflumilast
EP2506711B1 (en) *	2009-12-03	2019-04-03	OPKO Health, Inc.	Hypersulfated disaccharide formulations
FI3756650T3 (fi) *	2011-12-27	2025-10-30	Amgen Europe Gmbh	(+)-2-[1-(3-etoksi-4-metoksifenyyli)-2-metaanisulfonyylietyyli]-4-asetyyliaminoisoindoliini-1,3-dionin formulaatioita
CN103536582A (zh) *	2013-10-12	2014-01-29	云南龙海天然植物药业有限公司	罗氟司特干粉吸入剂
US20210031012A1 (en)	2018-01-26	2021-02-04	Progenity, Inc.	Treatment of a disease of the gastrointestinal tract with a pde4 inhibitor
WO2020106754A1 (en)	2018-11-19	2020-05-28	Progenity, Inc.	Methods and devices for treating a disease with biotherapeutics
WO2021119482A1 (en)	2019-12-13	2021-06-17	Progenity, Inc.	Ingestible device for delivery of therapeutic agent to the gastrointestinal tract

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4684516A (en) *	1983-08-01	1987-08-04	Alra Laboratories, Inc.	Sustained release tablets and method of making same
MY121142A (en) *	1999-02-23	2005-12-30	Smithkline Beecham Corp	Controlled release formulation for treating copd
AR035987A1 (es) *	1999-03-01	2004-08-04	Smithkline Beecham Corp	Uso de un compuesto inhibidor de la pde 4 para la manufactura de un medicamento y el medicamento para tratar asma inducida por ejercicio

2000
- 2000-10-26 CZ CZ20021443A patent/CZ20021443A3/cs unknown
- 2000-10-26 MX MXPA02004220A patent/MXPA02004220A/es unknown
- 2000-10-26 TR TR2002/01150T patent/TR200201150T2/xx unknown
- 2000-10-26 AU AU13445/01A patent/AU772909B2/en not_active Ceased
- 2000-10-26 NZ NZ518002A patent/NZ518002A/en unknown
- 2000-10-26 CO CO00081570A patent/CO5271676A1/es not_active Application Discontinuation
- 2000-10-26 IL IL14881300A patent/IL148813A0/xx unknown
- 2000-10-26 CA CA002389293A patent/CA2389293A1/en not_active Abandoned
- 2000-10-26 EA EA200200502A patent/EA200200502A1/ru unknown
- 2000-10-26 WO PCT/US2000/029453 patent/WO2001032165A1/en not_active Ceased
- 2000-10-26 EP EP00975385A patent/EP1225884A4/en not_active Withdrawn
- 2000-10-26 PL PL00355262A patent/PL355262A1/xx unknown
- 2000-10-26 HU HU0203682A patent/HUP0203682A3/hu unknown
- 2000-10-26 BR BR0015039-8A patent/BR0015039A/pt not_active IP Right Cessation
- 2000-10-26 CN CN00815150A patent/CN1387433A/zh active Pending
- 2000-10-26 AR ARP000105644A patent/AR026254A1/es not_active Application Discontinuation
- 2000-10-26 OA OA1200200126A patent/OA12078A/en unknown
- 2000-10-26 HK HK02109231.8A patent/HK1049105A1/zh unknown
- 2000-10-26 JP JP2001534370A patent/JP2003513038A/ja not_active Withdrawn
- 2000-10-26 DZ DZ003249A patent/DZ3249A1/fr active
- 2000-10-26 SK SK729-2002A patent/SK7292002A3/sk unknown
- 2000-10-26 AP APAP/P/2002/002446A patent/AP2002002446A0/en unknown
- 2000-10-26 KR KR1020027005448A patent/KR20020050249A/ko not_active Withdrawn
- 2000-10-27 PE PE2000001157A patent/PE20011004A1/es not_active Application Discontinuation
- 2000-10-30 UY UY26422A patent/UY26422A1/es not_active Application Discontinuation
2002
- 2002-04-17 BG BG106623A patent/BG106623A/bg unknown
- 2002-04-24 NO NO20021937A patent/NO20021937L/no not_active Application Discontinuation
- 2002-04-26 MA MA26618A patent/MA25562A1/fr unknown
2003
- 2003-05-02 US US10/429,666 patent/US20030212112A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CO5271676A1 (es)	2003-04-30
CN1387433A (zh)	2002-12-25
MA25562A1 (fr)	2002-10-01
EP1225884A1 (en)	2002-07-31
CA2389293A1 (en)	2001-05-10
DZ3249A1 (fr)	2001-05-10
HK1049105A1 (zh)	2003-05-02
SK7292002A3 (en)	2002-12-03
PL355262A1 (en)	2004-04-05
NO20021937D0 (no)	2002-04-24
BR0015039A (pt)	2002-06-25
AP2002002446A0 (en)	2002-03-31
OA12078A (en)	2003-05-28
MXPA02004220A (es)	2002-10-17
TR200201150T2 (tr)	2002-09-23
JP2003513038A (ja)	2003-04-08
WO2001032165A1 (en)	2001-05-10
IL148813A0 (en)	2002-09-12
CZ20021443A3 (cs)	2003-01-15
HUP0203682A2 (hu)	2003-04-28
EA200200502A1 (ru)	2002-10-31
AR026254A1 (es)	2003-02-05
US20030212112A1 (en)	2003-11-13
KR20020050249A (ko)	2002-06-26
PE20011004A1 (es)	2001-09-28
UY26422A1 (es)	2001-07-31
AU772909B2 (en)	2004-05-13
BG106623A (bg)	2003-02-28
NZ518002A (en)	2004-01-30
AU1344501A (en)	2001-05-14
HUP0203682A3 (en)	2003-10-28
EP1225884A4 (en)	2005-06-15

Publication	Publication Date	Title
EE9900517A (et)	2000-06-15	Tsüklooksügenaas-2 inhibiitorite kasutamise meetod südameveresoonkonna haiguste ärahoidmiseks
IS5739A (is)	2000-11-28	Efnasambönd óstöðugra DP IV-lata
ATE216997T1 (de)	2002-05-15	Zyklische gmp-spezifische phosphodiesteraseinhibitoren
DK1175400T3 (da)	2011-07-18	Renininhibitorer
EP1147107A4 (en)	2002-05-22	ANGIOGENESIS INHIBITORS
NO20021937D0 (no)	2002-04-24	Fremgangsmåte for administrering av en fosfodiesterase 4- hemmer
DE60035039D1 (de)	2007-07-12	Renin inhibitoren
EE03768B1 (et)	2002-06-17	Meetod bensimidasoolühendi sünteesiks
NO20010331L (no)	2001-03-20	Ftalazinderivater som fosfodiesterase 4-inhibitorer
PL329153A1 (en)	1999-03-15	Derivatives of pyrrolopyrolone as inhibitors of neutropil elastase
HUP0105011A3 (en)	2002-12-28	Synthesis method of nitroxymethylphenyl esters of aspirin derivatives
IL139450A0 (en)	2001-11-25	Methods of administering apo b-secretion/mtp inhibitors
NO20010298L (no)	2001-01-18	Polymorf av et formakum
NO20012976D0 (no)	2001-06-15	Anvendelse av inhibitorer av KQTI-kanalen for fremstilling av et medikament
NO20004288D0 (no)	2000-08-25	FremgangsmÕte til fremstilling av et beskyttet 4-aminometyl- pyrrolidin-3-on
NO20002174L (no)	2000-05-30	FremgangsmÕte for fremstilling av tiazolidindion-derivater
HUP0002083A3 (en)	2002-03-28	Synthesis of acridine derivative multidrug-resistant inhibitors
GB0111594D0 (en)	2001-07-04	Pipecolnic acid derivatives method of manufacturing the same and therapeutic agents containing these compounds
NO994049D0 (no)	1999-08-23	Metode for å fremstille farmasöytiske forbindelser
PL352374A1 (en)	2003-08-25	Inhibitors of integrine o v beta 6
NO20021028D0 (no)	2002-03-01	Fremgangsmåte for overflatemodifisering av en medisinsk slange
NO20003145D0 (no)	2000-06-16	FremgangsmÕte for fremstilling av paroxetine-hydroklorid
NO20016030L (no)	2002-01-30	Derivater av 4'-demykarosyl-8a-aza-8a-homotylosin
ID27591A (id)	2001-04-12	Proses pembuatan isoprop l-metil-[2-(3-n-propoksi-fenoksi) etil] amina
EA200000931A1 (ru)	2001-02-26	Анальгетическое средство "тетралгин" и способ его получения

Legal Events

Date	Code	Title	Description
2008-05-26	FC2A	Withdrawal, rejection or dismissal of laid open patent application